Volume | 74,770 |
|
|||||
News | - | ||||||
Day High | 15.47 | Low High |
|||||
Day Low | 15.14 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Alpine Income Property Trust Inc | PINE | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
15.35 | 15.14 | 15.47 | 15.47 | 15.29 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
735 | 74,770 | $ 15.39 | $ 1,150,476 | - | 14.25 - 17.76 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:10:00 | 8,111 | $ 15.47 | USD |
Alpine Income Property Trust Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
210.4M | 13.62M | - | 45.64M | 2.92M | 0.21 | 72.13 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Alpine Income Property News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PINE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.10 | 15.47 | 14.325 | 14.83 | 70,368 | 0.37 | 2.45% |
1 Month | 15.22 | 15.56 | 14.325 | 15.10 | 61,306 | 0.25 | 1.64% |
3 Months | 15.94 | 16.205 | 14.325 | 15.41 | 55,395 | -0.47 | -2.95% |
6 Months | 14.40 | 17.6799 | 14.25 | 15.84 | 58,424 | 1.07 | 7.43% |
1 Year | 16.09 | 17.76 | 14.25 | 16.01 | 71,415 | -0.62 | -3.85% |
3 Years | 18.50 | 21.069 | 14.25 | 17.70 | 73,200 | -3.03 | -16.38% |
5 Years | 19.00 | 21.069 | 7.56 | 17.11 | 69,809 | -3.53 | -18.58% |
Alpine Income Property Description
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. |